Celldex Therapeutics
CLDX
#4691
Rank
NZ$3.41 B
Marketcap
NZ$51.33
Share price
6.44%
Change (1 day)
13.11%
Change (1 year)

Celldex Therapeutics (CLDX) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$1.03 Billion

According to Celldex Therapeutics's latest financial reports the company has NZ$1.03 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celldex Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$1.32 B95.18%
2023-12-31$NZ$0.67 B32.09%
2022-12-31$NZ$0.51 B-16.34%
2021-12-31$NZ$0.61 B111.66%
2020-12-31$NZ$0.29 B107.83%
2019-12-31$NZ$0.13 B-24.51%
2018-12-31$NZ$0.18 B-44.43%
2017-12-31$NZ$0.33 B-13.14%
2016-12-31$NZ$0.38 B-9.6%
2015-12-31$NZ$0.42 B56.91%
2014-12-31$NZ$0.27 B-30.58%
2013-12-31$NZ$0.38 B234.26%
2012-12-31$NZ$0.11 B32.22%
2011-12-31$NZ$88.05 M-9.73%
2010-12-31$NZ$97.54 M-3.96%
2009-12-31$NZ$0.10 B225.02%
2008-12-31$NZ$31.24 M-2214.68%
2007-12-31$-NZ$1.48 Million-148.17%
2006-12-31$NZ$3.06 M-89.96%
2005-12-31$NZ$30.56 M-43.22%
2004-12-31$NZ$53.82 M25.32%
2003-12-31$NZ$42.95 M-28.29%
2002-12-31$NZ$59.89 M-45.06%
2001-12-31$NZ$0.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Seagen
SGEN
NZ$4.42 B 326.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-NZ$0.49 Billion-146.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.01 B-2.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.68 B 1,507.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.43 B 15,458.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$36.72 B 3,438.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
NZ$4.83 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA